Board of Directors
The Board of Directors manages the company on behalf of the Shareholders.
The Board of Directors manages the company on behalf of the Shareholders.
Chairman of the Board
Other assignments: CEO and owner of Aligned Clinical & Management Services, Shalmi Consulting ApS, Shalmi Invest ApS and Shalmi Holding ApS. CEO of P/S Momentum Energy Jutlandia, K/S Momentum Energy Jutlandia Development, K/S Momentum Energy Hanstholm, Momentum Energy Karrebæk Holding, Momentum Energy Karrebæk ApS and Momentum Energy Selandia ApS. Chairman of the board of Momentum Gruppen A/S, Momentum Energy Holding A/S and Curexsys GmbH. Board member of Momentum Energy Group A/S. Chairman of the Board, Curexsys GmbH, Germany.
Previous assignments (last five years): Board member of Evotec AG and Managing Director and Head of Principal Investments of Novo Holdings A/S.
Board Member
Other assignments: Chief Scientific Officer (CSO) at Xellia Pharmaceuticals, Board member of Pharmaero ApS and Member of the Scientific Selection Board of Novo Holdings – REPAIR Impact Fund.
Previous assignments: Head of European R&D for Barr Laboratories, Inc. and Member of Management Board of PLIVA Pharmaceuticals
Board Member
Other assignments: General Director of AGLS Life Science Consulting GmbH & Co. KG and Glasmacher Verwaltungs-GmbH. Board member and non-executive chairman of the board of 4D Pharma plc. Board member of AvenCell Therapeutics Inc. Member of the Supervisory board of Ryvu Therapeutics S.A. Board member and treasurer of the non-profit association Cancer Drug Development Forum asbl.
Previous assignments: Head of Global Clinical R&D and Senior Vice President for Celgene.
Board Member
Other assignments: Chairman of Medivir AB and Annexin Pharmaceuticals AB and Boardmember of Index Pharmaceuticals Holding AB and Synact Pharma AB.
Previous assignments (last five years): CEO of ACADIA Pharmaceuticals and CEO and Chairman of the Board of Cerecor.
Board Member
Other assignments: Board member and chair of R&D Committee of Nykode Therapeutics ASA. CEO of Keltic Pharma Therapeutics Ltd. Director in Dargle Therapeutics Ltd and Dargle Holdings Ltd. Non-executive director of IP Group Plc. Board member of Open Orphan plc. Member of supervisory board of Evotec A.G. Scientific advisor of Poolberg Pharma plc.
Previous assignments: CEO of Curadh Pharmaceuticals, Vice President Global External Research & Development at Lilly, Vice President R&D; Head of New Opportunities Therapy Area and Vice President, Science & Technology at Astra Zeneca and CEO and Co-Founder of Carrick Therapeutics.
Board Member
Other assignments: Chairman of the board of Brummer Investor Relations AB. Board member of B & P Fund services Aktiebolag, Brummer & Partners AB, Brummer Multi-Strategy AB, ELC Fastigheter AB, East Bay AB, Sjunda Gård AB, Sjuenda Holding AB, Sjunda Jordbruk AB, Sjunda Persbo Holding AB and S:ta Ragnhildgymnasiet AB.
Previous assignments (last five years): CEO of Carve Capital AB, Chairman of the board of directors of Jemtia AB, SRE Högfors AB and Acrux Entreprenad AB and Board member of CPB Energy AB, Valot Invest Sweden AB, Henvålens Fjällgård AB, Psoriasis + Creams Sweden AB and Järna Mejeri AB.